KOP’s Genomind Featured on Dr. Phil
King of Prussia’s Genomind, a personalized medicine company, was recently featured on an episode of Dr. Phil, writes John George of the Philadelphia Business Journal.
The company’s Genecept Assay – a genetic test designed to help clinicians make more informed treatment decisions for their patients with mental illness – was the focus of last Tuesday’s episode. The cheek swab test analyzes key genes to determine which medicines are likely to be the most effective for a person given his or her DNA makeup.
Dr. Phil McGraw, a psychologist and author, and his producers selected Genomind’s Genecept Assay to be highlighted as part of the program about helping a family in crisis.
The show told the story of a girl struggling with a variety of mental health challenges who has tried numerous treatments without success. Dr. Phil and the girl’s treating psychiatrist offered the Genecept Assay as a potential way to help reduce the time, expense, and struggle of finding the right treatment by trial and error.
Click here to read more about Genomind.
Stay Connected, Stay Informed
Subscribe for great stories in your community!
"*" indicates required fields